Kayne Anderson Rudnick Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230M | Buy |
|
|||||
|
2025
Q1 | $223M | Buy |
|
|||||
|
2024
Q4 | $207M | Buy |
|
|||||
|
2024
Q3 | $183M | Buy |
|
|||||
|
2024
Q2 | $196M | Buy |
|
|||||
|
2024
Q1 | $220M | Buy |
|
|||||
|
2023
Q4 | $157M | Buy |
|
|||||
|
2023
Q3 | $156M | Sell |
|
|||||
|
2023
Q2 | $186M | Buy |
|
|||||
|
2023
Q1 | $159M | Buy |
|
|||||
|
2022
Q4 | $103M | Buy |
|
|||||
|
2022
Q3 | $76.7M | Buy |
|
|||||
|
2022
Q2 | $87.2M | Buy |
|
|||||
|
2022
Q1 | $117M | Buy |
|
|||||
|
2021
Q4 | $126M | Sell |
|
|||||
|
2021
Q3 | $153M | Buy |
|
|||||
|
2021
Q2 | $123M | Buy |
|
|||||
|
2021
Q1 | $75.6M | Buy |
|
|||||
|
2020
Q4 | $70M | Buy |
|
|||||
|
2020
Q3 | $64.3M | Buy |
|
|||||
|
2020
Q2 | $49M | Buy |
|
|||||
|
2020
Q1 | $31.1M | Buy |
|
|||||
|
2019
Q4 | $29.2M | Buy |
|
|||||
|
2019
Q3 | $24.8M | Buy |
|
|||||
|
2019
Q2 | $20.3M | Buy |
|
|||||
|
2019
Q1 | $15.7M | Buy |
|
|||||
|
2018
Q4 | $12.6M | Buy |
|
|||||
|
2018
Q3 | $12.6M | Buy |
|
|||||
|
2018
Q2 | $8.66M | Buy |
|
|||||
|
2018
Q1 | $3.91M | Buy |
|
|||||
|
2017
Q4 | $3.6M | Buy |
|
|||||
|
2017
Q3 | $3.36M | Buy |
|
|||||
|
2017
Q2 | $3.26M | Buy |
|
|||||
|
2017
Q1 | $2.53M | Buy |
|
|||||
|
2016
Q4 | $2.22M | Buy |
|
|||||
|
2016
Q3 | $1.57M | Buy |
|